ClinicalTrials.Veeva

Menu

Evaluation of Rumination, Frailty and Tanatophobia in Cancer Patients Over 65 Years of Age (CANFRADE)

S

Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey

Status

Enrolling

Conditions

Death
Frailty
Cancer
Rumination

Study type

Observational

Funder types

Other

Identifiers

NCT05350007
CANFRADE

Details and patient eligibility

About

The aim of this study is to evaluate tanatophobia and rumination in individuals over 65 years of age receiving cancer chemotherapy and to determine the related factors.

Full description

No studies were found in the literature evaluating the relationship between frailty and lack of social support with tanatophobia and rumination. The aim of this study is to evaluate tanatophobia and rumination in individuals over 65 years of age receiving cancer chemotherapy and to determine the related factors.

Enrollment

180 estimated patients

Sex

All

Ages

65+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 65 years or older
  • Conscious and no communication problems
  • Being literate
  • Willing to participate in our study voluntarily
  • Cancer patient receiving active chemotherapy treatment

Exclusion criteria

  • Not being willing to participate in the research
  • Serious life-threatening condition (critical illness, intensive care unit stay, acute complication)
  • Dementia, Alzheimer's, cognitive dysfunction
  • Major psychiatric illness

Trial contacts and locations

1

Loading...

Central trial contact

Elif Yıldırım Ayaz, M.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems